Metraipolis › archive › dc_1b6840179cd0

Bridging to systemic therapy: PSMA-PET-based early and repetitive stereotactic body radiotherapy for nodal and bone oligo-recurrent prostate cancer — Europe PMC PMID:42769083

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42769083
DOI
10.3389/fruro.2026.1738508
License (as archived)
solo-consultazione
Archived
2026-10-15T23:31:09.433Z
SHA-256 of the archived text
857b43acff6afcfc38c1684aa259222d7de3c66cfa48c694bb713e7b717fc593
Stable URL of this page
https://metraipolis.com/documento/dc_1b6840179cd0

How to cite

Bridging to systemic therapy: PSMA-PET-based early and repetitive stereotactic body radiotherapy for nodal and bone oligo-recurrent prostate cancer — Europe PMC PMID:42769083 — Europe PMC (en), https://europepmc.org/article/MED/42769083 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1b6840179cd0 (Metraipolis archive dc_1b6840179cd0, sha256 857b43acff6afcfc38c1684aa259222d7de3c66cfa48c694bb713e7b717fc593)
BibTeX
@misc{dc1b6840179cd0,
  title = {Bridging to systemic therapy: PSMA-PET-based early and repetitive stereotactic body radiotherapy for nodal and bone oligo-recurrent prostate cancer — Europe PMC PMID:42769083},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42769083},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1b6840179cd0; sha256 857b43acff6afcfc38c1684aa259222d7de3c66cfa48c694bb713e7b717fc593},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42769083. Agents can read the archived copy with the MCP tool read_document.